Xin Li

Title: Innovations of Inventor Xin Li

Introduction

Xin Li is an accomplished inventor based in Solon, OH, with a focus on cancer research and detection. He holds two patents that contribute significantly to the field of oncology. His work emphasizes the importance of truncated proteins as cancer markers, which can lead to advancements in cancer detection and treatment.

Latest Patents

Xin Li's latest patents revolve around the use of truncated proteins as cancer markers. These patents disclose methods and reagents for detecting and treating cancers or potential cancers. In one embodiment, methods and reagents for detecting truncated forms of the P2X protein in cells are described. Additionally, the patents outline methods and reagents for increasing the amount and/or activity of full-length P2X in cells. Furthermore, they also detail methods and reagents for decreasing the amount and/or activity of truncated P2X in cells.

Career Highlights

Throughout his career, Xin Li has made significant contributions to medical research. He has worked with notable organizations, including the Henry M. Jackson Foundation for the Advancement of Military Medicine and University Hospitals of Cleveland. His work has been instrumental in advancing the understanding of cancer markers and potential treatments.

Collaborations

Xin Li has collaborated with esteemed colleagues in his field, including George Gorodeski and Ying-Hong Feng. These collaborations have further enriched his research and contributed to the development of innovative solutions in cancer detection and treatment.

Conclusion

Xin Li's contributions to cancer research through his patents and collaborations highlight his dedication to improving medical science. His innovative approaches to detecting and treating cancers position him as a significant figure in the field of oncology.